Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,213 across all filing types
Latest filing 2024-08-29 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and aggregate amounts. The document is a regulatory disclosure about share repurchase activity and changes in capital structure, not a full financial report or earnings release. It is not an announcement of a report publication but a detailed regulatory filing about share transactions. Therefore, the document fits best under the category of Transaction in Own Shares (POS).
2024-08-29 English
Interim Dividend for the six months ended 30 June 2024
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Cash Dividend Announcement for Equity Issuer' and provides detailed information about an interim dividend declared for the six months ended 30 June 2024. It includes dividend amount, payment dates, record dates, and other related administrative details. The document length is 3471 characters, which is relatively short and focused solely on dividend information. There is no financial statement, management discussion, or other report content. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2024-08-28 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Interim / Quarterly Report Classification · 95% confidence The document is titled 'ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024' and contains detailed financial and operational data for the six-month period ending June 30, 2024. It includes revenue figures, profit, dividend declaration, business review, and product sales analysis. The content is comprehensive and covers substantive financial data and business performance for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or publication notice. Therefore, the correct classification is IR with high confidence. H1 2024
2024-08-28 English
List of Directors and their Role and Function
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles, including committee memberships, effective from a specific date. It does not contain financial data, earnings, or detailed reports but is an announcement about the company's board composition and governance structure. This fits the category of Board/Management Information (MANG). The document length is short and focused solely on board membership changes, confirming it is not a full report or other filing type.
2024-08-28 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from a company listed on the Hong Kong Stock Exchange regarding the appointment of a new executive director, Ms. Qu Wanrong. It provides biographical details, terms of appointment, and compliance with listing rules. There is no financial data, no report or presentation attached, and the content focuses solely on management changes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-08-28 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement from the board of directors regarding the approval of drug production and registration for two pharmaceutical products by the National Medical Products Administration of China. It is an update on product development and does not contain financial statements, earnings data, or detailed management discussion. The document is relatively short (2420 characters) and serves to inform shareholders and investors about business developments rather than reporting financial results or governance changes. It is not an annual report, interim report, earnings release, or regulatory filing of financial nature. It is also not related to capital changes, voting results, or legal proceedings. Therefore, the most appropriate classification is a Regulatory Filing (RNS), which is a general category for announcements that do not fit other specific categories but are regulatory in nature and inform the market about company developments.
2024-08-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.